In The News: School of Integrated Health Sciences

Practical Neurology

Hallucinations and delusions are common in dementia and may be comorbid or part of the disease process (ie, dementia related psychosis [DRP]). DRP occurs in 30% of people with any type of dementia, 40% of those with Alzheimer disease and 70% of dementia with Lewy bodies.

Healthline

Performing certain exercises can help you manage spasticity after a stroke.

Healthline

Performing certain exercises can help you manage spasticity after a stroke.

Inc.

The counterintuitive lesson everyday people can steal from Olympic athletes.

MedPage Today

Not all physicians who treat Alzheimer's disease will prescribe the new Alzheimer's drug aducanumab (Aduhelm) -- major hospital systems like the Cleveland Clinic and Mount Sinai in New York City, for example, won't administer the controversial treatment -- but those who will offer the drug need more information about how to use it, a panel of neuroscientists said.

Practical Neurology

Appropriate use recommendations for the newly approved Alzheimer disease treatment, aducanumab (Aduhelm; Biogen, Cambridge, MA) have been published in The Journal of Prevention of Alzheimer’s Disease (JPAD).

McKnight's Long-Term Care News

Clinical experts have published the first set of clinical guidelines for appropriately using the newly approved Alzheimer’s drug aducanumab — brand name Aduhelm.

Endpoints News

Treatment of early Alzheimer’s patients with Biogen’s new drug Aduhelm should closely resemble how the drug was studied in its pivotal clinical trials, according to new recommendations from a panel of neuroscience experts led by UNLV’s Jeffrey Cummings.

Kiowa County Press

How do you get to the Olympics? Practice, practice, practice...

Newswise

A group of six leading Alzheimer’s experts have convened to make the first recommendations for the appropriate use of aducanumab (Aduhelm, Biogen/Eisai), a newly approved treatment for early Alzheimer’s disease.

Associated Press

Here’s a look at what The Conversation, a non-profit source of explanatory journalism from experts in academia, is offering today.

Conversation

How do you get to the Olympics? Practice, practice, practice…